Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVERS.L Regulatory News (VERS)

  • There is currently no data for VERS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blockchain agreement with Neuseren

11 Oct 2018 07:00

RNS Number : 7043D
Verseon Corporation
11 October 2018
 

BlockRules Ltd. and Neuseren S.A. bring regulation compliant securities offerings to the blockchain

Innovative blockchain platform supports the sale, issuance, and trading of regulated securities

Geneva and London, 11 October 2018-Geneva-based financial services firm Neuseren S.A. announced today that it has entered into an agreement with BlockRules Ltd., a blockchain development subsidiary of Verseon. Neuseren S.A. will use BlockRules' innovative technology and services to enable international companies to issue regulated tokenized securities on public blockchains.

Neuseren S.A. was established to fill the growing demand for tokenized security offerings for companies seeking to expand their investor base in a manner that satisfies regulatory requirements.

"The security and transparency of blockchain ledgers make them the ideal vehicle for financial securities," said Patrick Dumont, CEO of Neuseren. "One of the main barriers has been the lack of a framework to ensure regulatory compliance. BlockRules' technology provides that framework."

BlockRules' technology provides access to a new and growing global community of blockchain investors worldwide. Members of this community have a significant interest in utilizing a blockchain solution for securities trading, where built-in regulatory support is essential.

"Our blockchain technology brings companies and investors together in a way that can significantly improve the efficiency of capital markets," said Eniko Fodor, COO of Verseon and Director of BlockRules. "We believe our approach to supporting transactions of tokenized securities will create a new standard of trust and security for investors."

About Neuseren S.A.

Neuseren S.A. is a financial advisory company aiming to bring the latest blockchain innovations to corporate fund-raising. In line with best practices recognized by major regulatory authorities, the company intends to promote services and investor incentives for the sale and issuance of regulated tokenized securities on public blockchains.

About BlockRules Ltd.

BlockRules Ltd., a wholly owned subsidiary of Verseon Corporation, is a blockchain technology company supporting the sale, launch, and trading of securities. By enforcing multijurisdictional regulatory compliance directly on the blockchain, the company facilitates issuance and decentralized trading that is secure, transparent and verifiable.

--- ENDS ---

For additional information on Neuseren S.A., please contact:

Helen Gironi

info@neuseren.com

For addition information on BlockRules Ltd., please contact:

Robert Taylor

media@blockrules.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALIFFEISLLLIT
Date   Source Headline
18th Dec 20194:40 pmRNSSecond Price Monitoring Extn
18th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 20198:18 amRNSTender Offer Results & Special Meeting Notice
9th Dec 20197:00 amRNSResult of Special Shareholder Meeting
29th Nov 20199:05 amRNSSecond Price Monitoring Extn
29th Nov 20199:00 amRNSPrice Monitoring Extension
26th Nov 20192:05 pmRNSSecond Price Monitoring Extn
26th Nov 20192:00 pmRNSPrice Monitoring Extension
26th Nov 20197:00 amRNSCancellation of Depositary Interests Facility
25th Nov 20193:02 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSHolding(s) in Company
22nd Nov 201911:23 amRNSUpdate on Tender Offer
21st Nov 20194:40 pmRNSSecond Price Monitoring Extn
21st Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20194:33 pmRNSTransaction in Own Shares
20th Nov 20198:33 amRNSIssue of Debt
20th Nov 20197:30 amRNSProposed Cancellation of Admission to AIM
29th Oct 20197:00 amRNSResult of 2019 AGM
24th Oct 20199:43 amRNSUpdate on Facility Sale-Leaseback
23rd Oct 201911:28 amRNSSale-Leaseback of Verseon's Facility
18th Oct 20193:38 pmRNSAnnouncement of 2019 Annual General Meeting
17th Oct 20196:24 pmRNSHolding(s) in Company
16th Oct 20195:24 pmRNSHolding(s) in Company
30th Sep 20197:00 amRNSInterim Results
1st Aug 20194:40 pmRNSSecond Price Monitoring Extn
1st Aug 20194:35 pmRNSPrice Monitoring Extension
1st Aug 20192:05 pmRNSSecond Price Monitoring Extn
1st Aug 20192:00 pmRNSPrice Monitoring Extension
11th Jul 20193:43 pmRNSHolding(s) in Company
3rd Jul 20197:00 amRNSAdditional Listing & Total Voting Rights
28th Jun 20197:00 amRNSFinal Results
25th Jun 20197:00 amRNSAdditional Listing & Total Voting Rights
4th Jun 20197:00 amRNSVerseon showcases oral DME candidates at BIO 2019
30th Apr 20197:00 amRNSVerseon presents DME candidate at ARVO 2019
4th Apr 20197:00 amRNSAdditional Listing & Total Voting Rights
1st Apr 20194:10 pmRNSNew TIDM and ISIN for Subscription Shares
28th Mar 20197:00 amRNSFurther Update to Admission of Subscription Shares
22nd Mar 20197:00 amRNSUpdate to Admission of Subscription Shares
19th Mar 20197:00 amRNSResult of Subscription & Related Party Transaction
18th Mar 20197:00 amRNSVerseon announces security token offering
15th Mar 201912:00 pmRNSChange of TIDM
4th Mar 20197:00 amRNSAdditional Listing & Total Voting Rights
11th Feb 20197:00 amRNSVerseon presents low bleed PROACs at ISC 2019
4th Feb 20197:00 amRNSFirst participant dosed in Verseon clinical trial
29th Jan 20197:00 amRNSDirectorate Change
8th Jan 201912:00 pmRNSAdditional listing confirmation
3rd Jan 201910:20 amRNSAdditional Listing & Total Voting Rights
27th Dec 20187:00 amRNSAdditional Listing and Total Voting Rights
6th Nov 20187:00 amRNSResult of AGM and changes to the Board
5th Nov 20187:00 amRNSAdditional Listing & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.